367 related articles for article (PubMed ID: 27746256)
21. Metabolomic Alterations in Thyrospheres and Adherent Parental Cells in Papillary Thyroid Carcinoma Cell Lines: A Pilot Study.
Caria P; Tronci L; Dettori T; Murgia F; Santoru ML; Griffin JL; Vanni R; Atzori L
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262749
[TBL] [Abstract][Full Text] [Related]
22. Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.
Swierczynski J; Hebanowska A; Sledzinski T
World J Gastroenterol; 2014 Mar; 20(9):2279-303. PubMed ID: 24605027
[TBL] [Abstract][Full Text] [Related]
23. FoxO1-negative cells are cancer stem-like cells in pancreatic ductal adenocarcinoma.
Song W; Li Q; Wang L; Huang W; Wang L
Sci Rep; 2015 Jun; 5():10081. PubMed ID: 26068418
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G
Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151
[TBL] [Abstract][Full Text] [Related]
25. FASN multi-omic characterization reveals metabolic heterogeneity in pancreatic and prostate adenocarcinoma.
Chianese U; Papulino C; Ali A; Ciardiello F; Cappabianca S; Altucci L; Carafa V; Benedetti R
J Transl Med; 2023 Jan; 21(1):32. PubMed ID: 36650542
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Pancreatic and Biliary Cancer Stem Cells in Patient-derived Tissue.
Gogolok J; Seidel E; Strönisch A; Reutzel-Selke A; Sauer IM; Pratschke J; Bahra M; Schmuck RB
Anticancer Res; 2020 Mar; 40(3):1267-1275. PubMed ID: 32132023
[TBL] [Abstract][Full Text] [Related]
27. Proteomic Identification of FLT3 and PCBP3 as Potential Prognostic Biomarkers for Pancreatic Cancer.
Ger M; Kaupinis A; Petrulionis M; Kurlinkus B; Cicenas J; Sileikis A; Valius M; Strupas K
Anticancer Res; 2018 Oct; 38(10):5759-5765. PubMed ID: 30275197
[TBL] [Abstract][Full Text] [Related]
28. Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo.
Coleman O; Henry M; O'Neill F; Roche S; Swan N; Geoghegan J; Conlon K; McVey G; Moriarty M; Meleady P; Clynes M
Pancreas; 2020 Sep; 49(8):1109-1116. PubMed ID: 32833945
[TBL] [Abstract][Full Text] [Related]
29. Embryonic stem cell factors and pancreatic cancer.
Herreros-Villanueva M; Bujanda L; Billadeau DD; Zhang JS
World J Gastroenterol; 2014 Mar; 20(9):2247-54. PubMed ID: 24605024
[TBL] [Abstract][Full Text] [Related]
30. The mevalonate precursor enzyme HMGCS1 is a novel marker and key mediator of cancer stem cell enrichment in luminal and basal models of breast cancer.
Walsh CA; Akrap N; Garre E; Magnusson Y; Harrison H; Andersson D; Jonasson E; Rafnsdottir S; Choudhry H; Buffa F; Ragoussis J; Ståhlberg A; Harris A; Landberg G
PLoS One; 2020; 15(7):e0236187. PubMed ID: 32692762
[TBL] [Abstract][Full Text] [Related]
31. Nestin and other putative cancer stem cell markers in pancreatic cancer.
Matsuda Y; Kure S; Ishiwata T
Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
[TBL] [Abstract][Full Text] [Related]
32. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
[TBL] [Abstract][Full Text] [Related]
33. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis reveals Warburg effect and anomalous metabolism of glutamine in pancreatic cancer cells.
Zhou W; Capello M; Fredolini C; Racanicchi L; Piemonti L; Liotta LA; Novelli F; Petricoin EF
J Proteome Res; 2012 Feb; 11(2):554-63. PubMed ID: 22050456
[TBL] [Abstract][Full Text] [Related]
35. Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors.
Daemen A; Peterson D; Sahu N; McCord R; Du X; Liu B; Kowanetz K; Hong R; Moffat J; Gao M; Boudreau A; Mroue R; Corson L; O'Brien T; Qing J; Sampath D; Merchant M; Yauch R; Manning G; Settleman J; Hatzivassiliou G; Evangelista M
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):E4410-7. PubMed ID: 26216984
[TBL] [Abstract][Full Text] [Related]
36. Quantitative proteomic profiling studies of pancreatic cancer stem cells.
Dai L; Li C; Shedden KA; Lee CJ; Li C; Quoc H; Simeone DM; Lubman DM
J Proteome Res; 2010 Jul; 9(7):3394-402. PubMed ID: 20486718
[TBL] [Abstract][Full Text] [Related]
37. Glutathione peroxidase 4 maintains a stemness phenotype, oxidative homeostasis and regulates biological processes in Panc‑1 cancer stem‑like cells.
Peng G; Tang Z; Xiang Y; Chen W
Oncol Rep; 2019 Feb; 41(2):1264-1274. PubMed ID: 30535490
[TBL] [Abstract][Full Text] [Related]
38. KIF11 manipulates SREBP2-dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma.
Gu X; Zhu Q; Tian G; Song W; Wang T; Wang A; Chen X; Qin S
Cancer Med; 2022 Sep; 11(17):3282-3295. PubMed ID: 35619540
[TBL] [Abstract][Full Text] [Related]
39. Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
Ginestier C; Monville F; Wicinski J; Cabaud O; Cervera N; Josselin E; Finetti P; Guille A; Larderet G; Viens P; Sebti S; Bertucci F; Birnbaum D; Charafe-Jauffret E
Stem Cells; 2012 Jul; 30(7):1327-37. PubMed ID: 22605458
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations.
Zhou W; Capello M; Fredolini C; Piemonti L; Liotta LA; Novelli F; Petricoin EF
J Proteome Res; 2011 Apr; 10(4):1944-52. PubMed ID: 21309613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
